MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.
about
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.The Direct and Indirect Roles of NF-κB in Cancer: Lessons from Oncogenic Fusion Proteins and Knock-in Mice.The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex
P2860
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
MALT1 Inhibition Is Efficaciou ...... Chronic Lymphocytic Leukemia.
@en
MALT1 Inhibition Is Efficaciou ...... Chronic Lymphocytic Leukemia.
@nl
type
label
MALT1 Inhibition Is Efficaciou ...... Chronic Lymphocytic Leukemia.
@en
MALT1 Inhibition Is Efficaciou ...... Chronic Lymphocytic Leukemia.
@nl
prefLabel
MALT1 Inhibition Is Efficaciou ...... Chronic Lymphocytic Leukemia.
@en
MALT1 Inhibition Is Efficaciou ...... Chronic Lymphocytic Leukemia.
@nl
P2093
P2860
P1433
P1476
MALT1 Inhibition Is Efficaciou ...... Chronic Lymphocytic Leukemia.
@en
P2093
Adrian Wiestner
Ari Melnick
Chingiz Underbayev
Cydney M Nichols
Delong Liu
Eman L Dadashian
Erik K Flemington
Georges Tanios
Hana Safah
Jessica R Iyer
P2860
P304
P356
10.1158/0008-5472.CAN-17-2485
P407
P577
2017-10-09T00:00:00Z